Stoke Therapeutics names Alexander (Bo) Cumbo to board after Dr. Edward Kaye resignation

Stoke Therapeutics appointed Alexander (Bo) Cumbo to its Board as a Class III director, effective September 23, 2026, following the resignation of Edward M. Kaye, M.D.Original SEC Filing: Stoke Therapeutics, Inc. [ STOK ] - 8-K - Sep. 25, 2026This is an AI-powered summary. It may contain inaccuraci…